Santiago Ewig

Santiago Ewig's AcademicInfluence.com Rankings

Santiago Ewig

Philosophy

#9191

World Rank

#12712

Historical Rank

Logic

#6179

World Rank

#7667

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Santiago Ewig's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is Santiago Ewig Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Santiago Ewig's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. (2016) (2131)
Guidelines for the management of adult lower respiratory tract infections (2005) (945)
Guidelines for the management of adult lower respiratory tract infections ‐ Full version (2011) (793)
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. (1999) (661)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia (2017) (653)
Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies (1999) (491)
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. (1998) (471)
Severe community-acquired pneumonia. (1996) (446)
New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality (2009) (396)
Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. (2002) (386)
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. (2016) (385)
Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. (2002) (372)
Severe community-acquired pneumonia. Assessment of severity criteria. (1998) (371)
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. (1999) (363)
Guidelines for the management of adult lower respiratory tract infections--summary. (2011) (351)
Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. (1999) (345)
Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. (2000) (336)
Defining, treating and preventing hospital acquired pneumonia: European perspective (2008) (295)
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes (2008) (289)
CRB‐65 predicts death from community‐acquired pneumonia * (2006) (284)
Microbial aetiology of community-acquired pneumonia and its relation to severity (2011) (257)
Validation of predictive rules and indices of severity for community acquired pneumonia (2004) (256)
Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. (2014) (232)
Obstructive Sleep Apnea as a Risk Marker in Coronary Artery Disease (2000) (229)
Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. (2000) (221)
Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. (2010) (209)
Rethinking the concepts of community-acquired and health-care-associated pneumonia. (2010) (202)
Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. (2008) (197)
Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. (1999) (192)
Viral community-acquired pneumonia in nonimmunocompromised adults. (2004) (185)
Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. (1999) (182)
Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. (2006) (165)
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. (2013) (161)
Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. (2002) (160)
Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. (2009) (159)
Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. (1998) (155)
Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. (1999) (154)
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection (2010) (151)
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors (2009) (149)
Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet (2001) (140)
Acute Respiratory Distress Syndrome and Pneumonia: A Comprehensive Review of Clinical Data (2006) (124)
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZ (2009) (123)
Nursing home-acquired pneumonia: a 10 year single-centre experience (2010) (123)
Causes and predictors of nonresponse to treatment of intensive care unit–acquired pneumonia* (2004) (118)
Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis (2011) (111)
Sampling methods for ventilator-associated pneumonia: Validation using different histologic and microbiological references (2000) (110)
[SARS--Severe Acute Respiratory syndrome]. (2003) (110)
Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. (1998) (109)
Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. (1999) (105)
Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia* (2011) (103)
Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study (2011) (99)
Mixed community-acquired pneumonia in hospitalised patients (2006) (97)
[Management of Adult Community-acquired Pneumonia and Prevention - Update 2016]. (2016) (96)
Diagnosing ventilator-associated pneumonia. (2004) (86)
Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ) (2009) (85)
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD (2012) (83)
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients (2011) (83)
Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ (2010) (78)
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia (2012) (77)
Towards a sensible comprehension of severe community-acquired pneumonia (2011) (76)
Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. (1995) (74)
Community-acquired pneumonia as medical emergency: predictors of early deterioration (2015) (74)
Pseudomembranous and obstructive Aspergillus tracheobronchitis – optimal diagnostic strategy and outcome (2006) (74)
Susceptible, intermediate, and resistant - the intensity of antibiotic action. (2008) (74)
Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality (2011) (72)
Community-acquired pneumonia in outpatients: aetiology and outcomes (2012) (70)
Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. (2000) (69)
The prognostic significance of respiratory rate in patients with pneumonia: a retrospective analysis of data from 705,928 hospitalized patients in Germany from 2010-2012. (2014) (68)
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers (2012) (67)
Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors. (1998) (66)
Factors associated with unknown aetiology in patients with community-acquired pneumonia (2002) (65)
[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]. (2018) (65)
The pulmonary physician in critical care • 4: Nosocomial pneumonia (2002) (64)
Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. (1995) (63)
Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. (1998) (63)
Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. (2012) (62)
Assessment of pneumonia severity: a European perspective (2006) (61)
Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19 (2020) (59)
Is healthcare-associated pneumonia a distinct entity needing specific therapy? (2012) (58)
[Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAP (2009) (57)
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia (2007) (55)
Community-acquired pneumonia in younger patients is an entity on its own (2011) (54)
Severity assessment in community-acquired pneumonia. (2000) (54)
Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. (2010) (52)
Predictive diagnostic value of clinical assessment and nonlaboratory monitoring system recordings in patients with symptoms suggestive of obstructive sleep apnea syndrome. (1997) (52)
Burden and risk factors of ambulatory or hospitalized CAP: A population based cohort study. (2016) (52)
[Sleep apnea and cardiovascular risk]. (1995) (51)
Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia. (2010) (51)
Value of routine microbial investigation in community-acquired pneumonia treated in a tertiary care center. (1994) (51)
Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ. (2010) (47)
Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups (2012) (47)
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ (2012) (47)
How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia (2010) (46)
Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic (2010) (46)
Seasonality of pathogens causing community‐acquired pneumonia (2017) (45)
Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia (2016) (44)
Assessment of oxygenation and comorbidities improves outcome prediction in patients with community‐acquired pneumonia with a low CRB‐65 score (2015) (44)
Effects of bronchoalveolar lavage volume on arterial oxygenation in mechanically ventilated patients with pneumonia (2001) (44)
[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society]. (2020) (43)
Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations (2000) (41)
Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ. (2014) (41)
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia (2018) (39)
CRB-65 for the assessment of pneumonia severity: who could ask for more? (2008) (38)
Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance? (2001) (37)
C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ. (2009) (36)
A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis. (2006) (36)
Nosokomiale Pneumonie: Prävention, Diagnostik und Therapie (2003) (35)
Community-acquired pneumonia: definition, epidemiology, and outcome. (1999) (33)
Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay. (2016) (32)
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study (2009) (31)
Analysis of acute respiratory infections due to influenza virus A, B and RSV during an influenza epidemic 2018 (2019) (31)
Heart rate variability in patients with sleep-related breathing disorders. (1996) (28)
Prevention and management of ventilator-associated pneumonia (2002) (28)
Pigs might fly (2009) (26)
Admission lactate predicts poor prognosis independently of the CRB-/CURB-65-scores in community-acquired pnumonia (2017) (26)
Undiagnosed Diabetes Mellitus in Community-Acquired Pneumonia: A Prospective Cohort Study (2017) (26)
Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation. (1996) (25)
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatment. (2013) (24)
Initial management of primary spontaneous pneumothorax with video-assisted thoracoscopic surgery: a 10-year experience. (2016) (24)
Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation. (2000) (24)
Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia. (2019) (23)
Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. (2011) (21)
[Recommendations for therapy of community-acquired pneumonia. German Society of Pneumology]. (1998) (20)
MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit (2016) (20)
Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia (2016) (18)
Community-Acquired Pneumonia in Adults. (2017) (18)
A Comparison of Percutaneous Dilatational Tracheostomy Versus Conventional Surgical Tracheostomy (2014) (17)
Flexible bronchoscopy in nosocomial pneumonia. (2001) (17)
Defining severe community-acquired pneumonia. (2001) (17)
Respiratory microbiology patterns within the first 24 h of ARDS diagnosis: influence on outcome. (2005) (16)
Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia. (1996) (16)
Treatment failures in patients with ventilator-associated pneumonia. (2003) (16)
Pseudomembraneous Aspergillus fumigatus tracheobronchitis causing life-threatening tracheobronchial obstruction in a mechanically ventilated patient (2000) (16)
[S3-guideline on ambulant acquired pneumonia and deep airway infections]. (2005) (16)
Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials. (2019) (15)
Bronchopulmonary disposition of tobramycin after intratracheal administration (1994) (15)
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? (2003) (15)
Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. (2012) (14)
Hospital-acquired pneumonia in Europe (2009) (14)
Presentation, etiology and outcome of pneumonia in younger nursing home residents. (2012) (14)
Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence? (2002) (14)
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors (2016) (13)
Pro/con clinical debate: The use of a protected specimen brush in the diagnosis of ventilator associated pneumonia (2002) (12)
Does less surgical trauma result in better outcome in management of iatrogenic tracheobronchial laceration? (2019) (12)
Why Do Nonsurvivors from Community-Acquired Pneumonia Not Receive Ventilatory Support? (2013) (12)
Validation of a Prediction Score for Drug-resistant Microorganisms in Community-Acquired Pneumonia. (2020) (12)
Consort hypersensitivity pneumonitis (2009) (11)
Predicting in-hospital outcome in HIV-associatedPneumocystis carinii pneumonia (1995) (11)
[Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]. (2010) (11)
[Pleural empyema and lung abscess: current treatment options]. (2012) (11)
Nosocomial pneumonia: de-escalation is what matters. (2011) (11)
Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome (1999) (10)
Spencer’s Pathology of the Lung (2013) (10)
Fundamentals of High-Resolution Lung CT: Common Findings, Common Patterns, Common Diseases, and Differential Diagnosis (2013) (10)
Biomarkers in the diagnosis of pneumonia in the critically ill: don't shoot the piano player (2008) (10)
Acute exacerbations in chronic obstructive pulmonary disease (COPD)--microbial patterns and risk factors. (2000) (10)
Severity scores for CAP. ‘Much workload for the next bias’ (2010) (10)
[Position Paper on Adult Pneumococcal Vaccination: Position Paper of the German Respiratory Society and the German Geriatric Society]. (2015) (10)
M. pneumoniae and C. pneumoniae are no relevant pathogens in critically ill patients with hospital-acquired respiratory tract infections (2019) (10)
Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis. (2019) (10)
Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019? (2019) (10)
Adding fuel to the flames? It is time to leave HCAP. (2012) (9)
The strange case of community-acquired pneumonia in COPD. (2011) (9)
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany (2021) (9)
[Management of a new influenza A/H1N1 virus pandemic within the hospital: statement of the German Society of Pneumology]. (2009) (9)
Update Pneumonie 2012 (2012) (8)
[Therapy of nosocomial pneumonia]. (2000) (8)
Chronic Obstructive Pulmonary Disease and Infection: From Stable Patients to Pneumonia (1999) (8)
[Risk factors for pneumonia in patients with cardiovascular diseases]. (2002) (8)
Severe community-acquired pneumococcal pneumonia – what might be done better (1999) (8)
Prognosis of ventilator-associated pneumonia: what lies beneath (2011) (8)
The pneumonia triad (2014) (8)
[Nosocomial ventilator-associated pneumonias caused by Aspergillus fumigatus in non-immunosuppressed, non-neutropenic patients]. (1998) (8)
[Nosocomial pneumonia: prevention, diagnosis, treatment]. (2003) (8)
Ecology and environmental sources of legionella (2007) (8)
[Diagnosis and treatment of legionella pneumonia]. (2002) (8)
Severe acute respiratory syndrome (SARS) (2003) (7)
[Sleep apnea as a risk marker in coronary heart disease]. (1996) (7)
[A new look at lung abscess. Clinical treatment-related classification]. (2001) (7)
A simple procalcitonin-guided strategy results in safe reductions of antibiotic use in patients with symptoms of acute respiratory tract infections in primary care (2010) (7)
Nosocomial and Ventilator-Associated Pneumonia (2011) (6)
Severe community-acquired pneumonia: how to assess illness severity. (1999) (6)
HCAP not busy being born is busy dying. (2014) (6)
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment E cacy in Future Hospital- acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials (2019) (6)
Approaches to suspected ventilator-associated pneumonia: relying on our own bias (2001) (6)
Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia. (2020) (6)
Diagnosis of ventilator-associated pneumonia: nonroutine tools for routine practice. (1996) (6)
Management of suspected ventilator-associated pneumonia. (2000) (6)
[The Role of Air Pollutants for Health - A Reply to the Expert Opinion of the International Society for Environmental Epidemiology (ISEE) and the European Respiratory Society (ERS)]. (2019) (6)
Severe Complications of Ultrasound Guided Transbronchial Needle Aspiration – A Case Series and Review of the Literature (2016) (6)
Gains and limitations of predictive rules for severe community-acquired pneumonia. (2011) (5)
[Treatment with Dexamethasone in Patients with COVID-19 - A Position Paper of the German Respiratory Society (DGP)]. (2020) (5)
[Guidelines for the Management of Community Acquired Pneumonia in Children and Adolescents (Pediatric Community Acquired Pneumonia, pCAP) - Issued under the Responsibility of the German Society for Pediatric Infectious Diseases (DGPI) and the German Society for Pediatric Pulmonology (GPP)]. (2020) (5)
[PleurX drainage catheter for palliative treatment of malignant pleural effusion]. (2012) (5)
Minimally Invasive Thoracic and Cardiac Surgery: Textbook and Atlas (2013) (5)
Pneumonia in the elderly--what makes the difference? (2000) (5)
Video-Assisted Thoracoscopic Surgery of Parapneumonic Empyema – a 10-year Single-Centre Experience (2018) (5)
Severe community-acquired pneumonia (1997) (5)
The effect of prophylaxis on the outcome of HIV-associated Pneumocystis carinii pneumonia. (1996) (5)
[Treatment of community-acquired lung abscess associated with aspiration]. (2001) (4)
Laboratory aspects of Legionella. (2007) (4)
[Heart rate variability in patients with sleep associated breathing disorders]. (1997) (4)
Healthcare-associated pneumonia: meeting the yeti (2011) (4)
Bronchopulmonary infection with Mycobacterium malmoense presenting as a bronchoesophageal fistula. (1996) (4)
[Cardiovascular morbidity in patients with obstructive sleep apnea in relation to the severity of respiratory disorder]. (1998) (4)
Protected Bronchoalveolar Lavage for the Diagnosis of Hiv-associated Pneumonia (1998) (4)
[Nocardiosis as a differential diagnosis of a PET-positive pulmonary nodule]. (2007) (4)
Against misleading predictions for severe community-acquired pneumonia. (2007) (4)
Antibiotics and the Lung (2004) (4)
Pneumocystis carinii infections in HIV-infected hemophiliacs during aerosolized pentamidine prophylaxis. (1993) (4)
[Independent radiologic prognostic factors for fatal outcome of ambulatory-acquired pneumonia requiring inpatient treatment]. (1999) (3)
Body fat distribution and cardiovascular risk factors in men with obstructive sleep apnea (OSA) (2001) (3)
β-Lactam-Antibiotika in der Therapie von ambulant erworbenen Atemwegsinfektionen mit Penicillin-resistenten Pneumokokken (2002) (3)
Diagnosis of Peripheral Lung Lesions by EBUS-Guided TBB in Routine Practice (2011) (3)
[Recommendations for the diagnosis, therapy and prevention of pneumonia in the immunocompromised host]. (2002) (3)
PSEUDOMONAS AERUGINOSA AND INITIAL ANTIBIOTIC CHOICES (2001) (3)
Image-based lung functional radiotherapy planning for non-small cell lung cancer (2019) (3)
[Diagnosis of infections in pneumology]. (2010) (3)
A new tool for an old disease (2004) (3)
Tracheal Perforation by an Oesophageal Stent (2012) (3)
Diagnosis of Pneumocystis carinii infection in HIV-seropositive patients by identification of P carinii in pleural fluid. (1994) (3)
[German Society of Pneumology. Recommendations for the diagnosis of nosocomial infections]. (1999) (3)
Intrapulmonary neutrophil apoptosis in a pig model of pneumonia. (2002) (2)
[48-Year-Old Triathlete with Severe COVID-19 Pneumonia: Successful and Safe Treatment with Oxygen and CPAP]. (2020) (2)
[Long-term outcome of intrapleural fibrinolytic therapy via small-bore catheter drainage in the management of complicated parapneumonic effusion and empyema-a case series]. (2005) (2)
Pneumocystis carinii pneumonia presenting as an upper lobe cavity after aerosolized pentamidine prophylaxis in an HIV-infected patient. (1993) (2)
Questions with inconclusive answers (2002) (2)
Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges (2008) (2)
[Nosocomial pneumonia: recommendations on treatment and prevention. German Pneumology Society] . (2000) (2)
[Therapeutic options in the management of stable chronic obstructive lung disease (COPD)]. (2008) (2)
Hot off the breath : the 2009 H 1 N 1 flu pandemic may be gone but should not be forgotten (2010) (2)
[SARS. A lesson in infection epidemiology and a masterpiece of modern infection control]. (2003) (2)
[Management of a new influenza A/H1N1 virus pandemic within the hospital. Statement of the German Society of Pneumology]. (2010) (2)
[Validation of diagnostic techniques in ventilator-assisted pneumonia--a critical appraisal]. (1999) (2)
[Update: Guidelines for the treatment and prevention of adult community-acquired pneumonia 2016: what is new?] (2017) (2)
Community-acquired Pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa : Diagnosis , Incidence and Predictors The German Competence Network for Community-acquired pneumonia ( CAPNETZ ) (2009) (2)
Ventilator-assoziierte Pneumonie (2014) (2)
Role of multidrug-resistant pathogens in health-care-associated pneumonia – Authors' reply (2011) (2)
PCR-based routine diagnostics uncover hidden burden of Legionnaires' disease. (2019) (2)
Predictors of Outcomes in Patients with Prolonged Weaning with Focus on Respiratory Tract Pathogens and Infection (2018) (2)
Pneumocystis carinii pneumonia (2003) (2)
Infektionsdiagnostik in der Pneumologie Teil 2: Nachweis von bakteriellen Mikroorganismen aus dem Tracheobronchialsystem: Infektion oder Kolonisation? Diagnosis of Infections in Pneumology Part II: Detection of Bacterial Microorganisms from the Tracheobronchial System: Infection or Colonisation? (2010) (2)
Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia (2012) (2)
[Central airway obstruction in ulcerative colitis - a rare extraintestinal manifestation]. (2006) (2)
Pneumonia in the immunosuppressed host – a general clinical approach (2006) (2)
[Tuberculosis in Germany from 2001 onwards]. (2001) (2)
[ECMO Therapy in a Case of Severe ARDS Related to COVID-19]. (2020) (1)
Drug-Resistant Streptococcus pneumoniae: Impact on Diagnosis and Treatment of Community-Acquired Pneumonia (2001) (1)
Comparison of the inflammatory response in ARDS and pneumonia: possible implication for the differential diagnosis (1999) (1)
Another view on the prediction of outcomes in patients with community-acquired pneumonia (2011) (1)
[39-year-old patient presenting with aspiration pneumonia due to high hypomotile achalasia]. (2006) (1)
[Non-passable tumor-associated stenosis of trachea and stent-implantation -- an indication for Virtual CT-bronchoscopy]. (2005) (1)
[Sleep apnea and chronic obstructive respiratory tract disease (COPD): diagnostic and therapeutic consequences]. (1996) (1)
[Diagnostic and therapeutic criteria for nosocomial pneumonia]. (2000) (1)
[Antimicrobial treatment of patients with severe acute exacerbation of COPD]. (2012) (1)
[Community-acquired pneumonia requiring inpatient treatment: outcome and prognostic rule]. (1996) (1)
DEFINING SEVERE PNEUMONIA COMMUNITY-ACQUIRED (2001) (1)
Community-Acquired Pneumonia: Staphylococcus aureus (2002) (1)
[Community-acquired pneumonia]. (2016) (1)
Tracheal Perforation by an Oesophageal Stent Tracheaperforation durch einen Ösophagusstent (2012) (1)
Reply to van Saene et al. (2009) (1)
A New Spotlight on Pulmonary Abscesses (2001) (1)
[Improved prognosis of first episode HIV associated Pneumocystis carinii pneumonia without preventive treatment: etiology and sequelae]. (1996) (1)
[The benign metastasizing leiomyoma: case collection and therapeutical options]. (2007) (1)
Pulmonary Complications Of Pneumococcal CAP: Incidence, Predictors, And Outcomes (2012) (1)
[Diagnosis of pneumonia in artificial ventilation: principles, techniques, results, preliminary recommendations]. (1996) (1)
[Informations and recommendations of the German Respiratory Society and the Paul-Ehrlich-Society for chemotherapy concerning the outbreak of influenza A(H7N9) virus infections in humans]. (2013) (1)
[Nosocomial pneumonia: diagnosis]. (2006) (1)
Severe Acute Exacerbations of COPD: Epidemiology and Antimicrobial Treatment (2000) (1)
[Alternatives to standard therapy for bronchial asthma]. (2000) (1)
STREPTOCOCCUS PNEUMONIAE IN COMMUNITY-AQUIRED PNEUMONIA (2001) (1)
[Therapy of community-acquired pneumonia]. (2000) (1)
[Successful treatment of chronic necrotizing pulmonary aspergillosis with oral itraconazole long-term therapy]. (1999) (1)
[Management of severe pulmonary alveolar proteinosis: how to perform whole-lung lavage safely]. (2011) (1)
Ventilator-associated pneumonia: approaching the horizon (2010) (1)
Subject Index Vol. 87,1996 (1996) (0)
[Diagnosis of nosocomial pneumonia: noninvasive but not undirected]. (2007) (0)
[Revisited: Michael Balint. The doctor, his patient and the illness]. (2010) (0)
[Nodular pulmonary opacities caused by a severe suppurative bronchitis and bronchiectases]. (2008) (0)
Pathogen Directed Antimicrobial Treatment of Pneumonia (2008) (0)
Pneumonie unter allogener Stammzelltransplantation (2017) (0)
[Successful risk management in flexible bronchoscopy]. (2009) (0)
Ambulant erworbene Aspirationspneumonie (2015) (0)
[HIV-associated Pneumocystis carinii pneumonia, primary pentamidine inhalation prophylaxis notwithstanding. Are there differences with Pneumocystis carinii pneumonia without prophylaxis?]. (1996) (0)
Catch me if you can – Das endobronchiale Lipom (2012) (0)
PREDICTIVE FACTORS FOR DEATH IN PAEDIATRIC ACUTE RESPIRATORY FAILURE. AUTHOR'S REPLY (1995) (0)
[Diagnosis of community-acquired pneumonia]. (2000) (0)
Definitionen und Typen der Immunsuppression (2018) (0)
Pneumonie unter HIV-Infektion (2018) (0)
[A new series: "Update: pathogens involved in respiratory infections"]. (2002) (0)
[Pulmonary manifestations in adult rheumatic diseases]. (2021) (0)
John Alexander Nakhosteen (1937 – 2012) (2012) (0)
8.1 Chemotherapeutika Chemotherapeutikum Charakteristikum (2015) (0)
[Quantitative cultures in diagnosis of pneumonia--a method for routine practice?]. (1998) (0)
[Infections in Patients with Home Ventilation]. (2017) (0)
[Sleep-related respiratory disorders in patients with implantable cardioverter/defibrillator devices--relationship between left ventricular function and respiratory disorder]. (1995) (0)
Internistische Therapie 2016/2017 (2016) (0)
STREPTOCOCCUS PNEUMONIA€ PNEUMONIA IN COMMUNITY-ACQUIRED How Important Is Drug Resistance? (2001) (0)
Therapieversagen (2017) (0)
Ambulant erworbene Pneumonie: Pathophysiologie (2015) (0)
The Best on Infections, update from the 2010 ERS Conference (2011) (0)
Community-Acquired Pneumonia in Immunocompromised Adults: Solid Tumors Might Not Be Regarded as Independent Risk Factors for Opportunistic Pathogens. (2020) (0)
Pulmonary rehabilitation in patients with MRC Dyspnoea (2011) (0)
Prognostic a analysis a and p predictive rrule ffor o outcome of h hospital-treated c community-acquired p pneumonia (1995) (0)
[Guidelines and conflicts of interest: where are we, where do we go from here?]. (2013) (0)
[Tuberculosis 2012--update of recommendations for the management of tuberculosis in Germany]. (2012) (0)
Pneumonie unter Immunsuppression (2018) (0)
Community acquired infections in secondary care (2012) (0)
[An invasive bronchoscopic strategy in the treatment of patients with suspected ventilator-associated pneumonia is not a superior clinical strategy]. (2000) (0)
[Pulmonary aspergillosis in patients without pre-existing pulmonary disease after brain edema prevention with dexamethasone]. (1999) (0)
[beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci]. (2002) (0)
“Community-acquired pneumonia in younger patients is an entity on its own.” Benjamin Klapdor, Santiago Ewig, Mathias W. Pletz, Gernot Rohde, Hartwig Schütte, Tom Schaberg and Tobias Welte for the CAPNETZ study group. Eur Respir J 2012; 39: 1156–1161. (2012) (0)
[Medicine and Economy Today]. (2019) (0)
[Cough, exertional dyspnea and cystic lung changes in a 28-year-old patient]. (1997) (0)
Reply to Salvatore and colleagues (2014) (0)
Nosocomial pneumonia (2006) (0)
Pneumonie unter Immunsuppression: Bronchoskopische Diagnostik (2017) (0)
Quantitative Kulturen in der Pneumoniediagnostik — eine Methode für die Routine? (1998) (0)
Ambulant erworbene Pneumonie: Definitionen (2016) (0)
List of reviewers 2010 (2011) (0)
[Not Available]. (2013) (0)
The best on infections: update from the 2010 ERS Congress (2011) (0)
Severe Pneumonia in the Elderly (1999) (0)
[Chronic rhinosinusitis--a common piece in pneumological puzzles]. (2013) (0)
Erreger (2016) (0)
Austrian Respiratory Society , the Austrian Society for Infectious and Tropical Diseases and the Swiss Respiratory Society (2016) (0)
[Intensive therapy of acute respiratory insufficiency in HIV infected patients. Current decision guidelines and therapy options]. (1997) (0)
[Do Respiratory Physicians Have to Advocate Clean Air? - A Contribution to the 70th Anniversary of the Constitution of the Federal Republic of Germany]. (2019) (0)
Ambulant erworbene Pneumonie: Therapieversagen (2015) (0)
Authors' response (2010) (0)
SERIES "RECENT DEVELOPMENTS IN PULMONARY INFECTIONS" Edited by M. Woodhead and T. Schaberg Number 2 in this Series Severity assessment in community-acquired pneumonia (2000) (0)
Pulmonary Infiltrates inNeutropenic Patients WithAcuteLeukemiaDuring Chemotherapy* OutcomeandPrognostic Factors (2017) (0)
26 Mycobacterium kansasii (2016) (0)
Carinal sleeve resection: last exit for bronchial insufficiency-a 17-year, single-centre experience. (2021) (0)
Community-Acquired Pneumonia in Alcoholic Patients (2007) (0)
Ambulant erworbene Pneumonie: Komplikationen (2015) (0)
[Thoracic actinomycosis: diagnostic pitfalls and therapeutic considerations]. (2009) (0)
[From physiopathology to new developments in pharmacotherapy of bronchial asthma--a look into the future]. (2000) (0)
[Community-acquired pneumonia--treatment perspectives in the physician's office]. (2004) (0)
Pneumonie unter Neutropenie (2018) (0)
PES Score validation in a multicenter Cohort of patients with community-acquired pneumonia (2019) (0)
| Respiratory Infections | Taylor & Francis Group (2006) (0)
Adult Patients With Nosocomial Pneumonia (2013) (0)
[Moving from ventilatory support to the ICU to ventilation on the ward. Respiratory medicine is crucial in the management of acute respiratory failure due to pandemic avian influenzavirus infection]. (2005) (0)
In reply. (2014) (0)
[Lobectomy of Right Lower Lobe Eight Years after Foreign Body Aspiration]. (2019) (0)
Severe Pneumonia: Definition of Severity (2005) (0)
Evaluation of moxifloxacin (MXF) as empiric antibiotic therapy of CAP outpatients: A multicenter prospective study (2012) (0)
Contents, Vol. 87, 1996 (1996) (0)
Pneumonia in the immunocompromised host (2019) (0)
Pneumonie unter Immunsuppression: Antimikrobielle Substanzen (2017) (0)
Biomarkers and VAP: results and perspectives (2011) (0)
Pulmonary infections and sepsis (2011) (0)
[Bullectomy as emergency intervention in a mechanically ventilated patient with refractory type II respiratory failure due to chronic obstructive lung disease (COPD)]. (2008) (0)
Reply to Corrao et al. (2014) (0)
Tracheal surgery in Germany (2020) (0)
[Polycystic and cavernous course of pneumocystis carinii pneumonia in AIDS]. (1994) (0)
[Diagnostic value of protected bronchoalveolar lavage in HIV-associated pneumonia]. (1995) (0)
Should quantitative cultures be routinely used in diagnostic worn-up of pneumonia? (1998) (0)
Validation of the qSOFA(-65) score compared to the CRB-65 score for risk prediction in community-acquired pneumonia (2022) (0)
Bacterial co-infections in community acquired pneumonia cases of 2009 pandemic-influenza A (H1N1) virus in Spain (2011) (0)
[Comprehensive Preoperative Evaluation of Patients with Lung Cancer]. (2020) (0)
[Healthcare-associated pneumonia - is this new entity important for diagnosis and treatment of pneumonia? contra]. (2010) (0)
[A new concept for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)]. (2006) (0)
Burden and risk factors of ambulatory and hospitalized CAP: a population based cohort study (2016) (0)
Clinical c characteristics a and o outcome o of Pneumocystis c carinii pneumonia iin H HIV-infected and o otherwise iimmunosuppressed p patients (1995) (0)
Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP) (2011) (0)
Section D: Non-antimicrobial therapies (2006) (0)
[Therapeutic failure in acquired ambulatory pneumonia. Causes and differential diagnosis]. (2001) (0)
Effect of long-term primary aerosolized pentamidine prophy- laxis on breakthrough Pneumocystis carinii pneumonia (2002) (0)
25 Mycobacterium avium-Komplex (2016) (0)
[The diagnosis of pneumonia in daily practice: how many diagnostic measures are essential?]. (2001) (0)
From the authors (2006) (0)
[Good sense and nonsense of antitussive agents]. (2001) (0)
[Comprehensive Preoperative Evaluation of Patients with Lung Cancer]. (2019) (0)
Chapter 6. Neutropenia (2009) (0)
4.3 Tumorstaging Diagnostik Tumorstaging Tumor Staging (2015) (0)
Moxifloxacin in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). (2009) (0)
[Nosocomial pneumonia: therapy]. (2006) (0)
[Complicated community-acquired pneumonias do not need invasive bronchoscopic pathogen diagnosis in routine management]. (1997) (0)
[Diagnosis of infections in pneumology]. (2010) (0)
Ventilator-associated Pneumonia: What are the Accuracies and the Consequences of Different Diagnostic Methods (2005) (0)
[Sleep apnea and animal models--how relevant for clinical practice?]. (2008) (0)
[Kaleidoscope of History 2003 - 2016]. (2016) (0)

This paper list is powered by the following services:

Santiago Ewig's Academic­Influence.com Rankings

Santiago Ewig's Degrees

Why Is Santiago Ewig Influential?

Santiago Ewig's Published Works

Published Works

Santiago Ewig's AcademicInfluence.com Rankings